CXCR3 and myeloid sarcoma: We find that TH1/17 cells in patients with MS have elevated expression of CXCR3 and reduced expression of IL10. It has been shown that CXCL10 (IP-10), a ligand for CXCR3, is increased in the inflamed CNS of MS41–44.